✦ LIBER ✦

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

✍ Scribed by Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yutaka; Kuki, Hideki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of canagliflozin in

✍ Inagaki, N.; Kondo, K.; Yoshinari, T.; Maruyama, N.; Susuta, Y.; Kuki, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

Efficacy and safety of canagliflozin mon

✍ Stenlöf, K.; Cefalu, W. T.; Kim, K.-A.; Alba, M.; Usiskin, K.; Tong, C.; Canovat 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 832 KB

Efficacy and safety of dapagliflozin mon

✍ Kaku, K.; Kiyosue, A.; Inoue, S.; Ueda, N.; Tokudome, T.; Yang, J.; Langkilde, A 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 948 KB

Dapagliflozin Monotherapy in Type 2 Diab

✍ Ferrannini, E.; Ramos, S. J.; Salsali, A.; Tang, W.; List, J. F. 📂 Article 📅 2010 🏛 American Diabetes Association 🌐 English ⚖ 326 KB

Long-term efficacy and safety of canagli

✍ Stenlöf, Kaj; Cefalu, William T.; Kim, Kyoung-Ah; Jodar, Esteban; Alba, Maria; E 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 737 KB

Efficacy and safety of initial combinati

✍ R. Gomis; R.-M. Espadero; R. Jones; H. J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB